retatrutide phase 2 trial type 2 diabetes weight loss Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released results demonstrating 25% in half of people with #obesity. This amount of weight loss has not been accomplished Triple hormone receptor agonist retatrutide

Stentebjerg LL, Madsen LR, Stving RK, Andersen LLT, Vinter CA, Juhl CB, et al

Red or pink urine May indicate blood in urine (hematuria) or food/medication pigments

This naturally leads to reduced calorie intake, which contributes to weight loss

If Aetna still says no, you can request an external review within 120 daysan independent organization reviews your case, and external reviewers often rule in the patient's favor

As with women's health considerations, these questions require individualized clinical evaluation by the prescribing provider

What to do: Include resistance exercise in your weekly routine Eat enough high-quality protein throughout the day Work with a dietitian to support muscle preservation during weight loss 2